GlassScriptPhysician profile
Daniel Ciaburri
NPI 1710002910
$12,187.92
in general payments reported to CMS, 2019-2025
15 companies · $84.54 in 2025
The $84.54 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,052 · 2020: $778 · 2021: $1,219 · 2022: $555 · 2023: $98.80 · 2024: $401 · 2025: $84.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $584.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,352.67 | 2019 | |
| Atricure, INC. | $1,698.17 | 2021-2024 | |
| Edwards Lifesciences Corporation | $975.05 | 2020-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $194.19 | 2021-2025 | Corevalve Evolut R |
| Davol INC. | $163.72 | 2019 | |
| Medtronic Vascular, INC. | $127.97 | 2019 | |
| Bard Access Systems, INC. | $126.43 | 2019 | |
| Livanova USA, INC. | $89.57 | 2019-2025 | Perfusion Tubing |
| Bolton Medical INC | $87.80 | 2019 | |
| Abiomed | $80.57 | 2020 | |
| Cerus Corporation | $77.78 | 2024 | Intercept Blood System For Platelets |
| Conmed Corporation | $71.43 | 2019 | |
| Becton, Dickinson and Company | $60.17 | 2019 | |
| Zimmer Biomet Holdings, INC. | $58.47 | 2022-2023 | Sternalock Blu System |
| Artivion, INC. | $23.93 | 2023 | Bioglue Surgical Adhesive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ciaburri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.